Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial; The Journal of Thoracic and Cardiovascular Surgery; Vol. ХХХ
| Parent link: | The Journal of Thoracic and Cardiovascular Surgery Vol. ХХХ.— 2018.— [10 p.] |
|---|---|
| Korporativna značnica: | |
| Drugi avtorji: | , , , , |
| Izvleček: | Title screen Objectives - The aim of this pilot study was to elucidate the effects of exogenous nitric oxide <https://www.sciencedirect.com/topics/medicine-and-dentistry/nitric-oxide>(NO) supply to the extracorporeal circulation <https://www.sciencedirect.com/topics/medicine-and-dentistry/extracorporeal-circulation> circuit for cardioprotection <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-protection> against -ischemiareperfusion injury <https://www.sciencedirect.com/topics/medicine-and-dentistry/reperfusion-injury> during coronary artery bypass grafting <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-bypass-graft> (CABG) with cardiopulmonary bypass <https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiopulmonary-bypass> (CPB). Methods -A total of 60 patients with coronary artery disease <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-disease> scheduled for CABG with CPB were enrolled in a prospective randomized study. Patients were allocated randomly to receive treatment according to standard or modified CPB protocol where 40-ppm NO was added to the CPB circuit during cardiac surgery <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-surgery>. The primary endpoint was the measurement of cardiac troponin I <https://www.sciencedirect.com/topics/medicine-and-dentistry/troponin-i> (cTnI). The secondary end points consisted in the measurements of creatine kinase-muscle/brain fraction (CK-MB) and vasoactive inotropic <https://www.sciencedirect.com/topics/medicine-and-dentistry/inotropism> score (VIS). Results - NO delivered into the CPB circuit had a cardioprotective effect. The level of cTnI was significantly lower in NO-treated group compared with the control group 6 hours after surgery: 1.79 ± 0.39 ng/mL versus 2.41 ± 0.55 ng/mL, respectively (P = .001). The CK-MB value was significantly lower in NO-treated group compared with the control group 24 hours after surgery: 47.69 ± 8.08 U/L versus 62.25 ± 9.78 U/L, respectively (P = .001); and the VIS was significantly lower in the NO-treated group 6 hours after the intervention. Conclusions - NO supply to the CPB circuit during CABG exerted a cardioprotective effect and was associated with lower levels of VIS and cardiospecific blood markers cTnI and CK-MB. Режим доступа: по договору с организацией-держателем ресурса |
| Jezik: | angleščina |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://doi.org/10.1016/j.jtcvs.2018.08.117 |
| Format: | Elektronski Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=659550 |
MARC
| LEADER | 00000naa0a2200000 4500 | ||
|---|---|---|---|
| 001 | 659550 | ||
| 005 | 20250321171203.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\28160 | ||
| 035 | |a RU\TPU\network\20090 | ||
| 090 | |a 659550 | ||
| 100 | |a 20190227d2018 k||y0rusy50 ba | ||
| 101 | 0 | |a eng | |
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial |f N. O. Kamenshchikov [et al.] | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 330 | |a Objectives - The aim of this pilot study was to elucidate the effects of exogenous nitric oxide <https://www.sciencedirect.com/topics/medicine-and-dentistry/nitric-oxide>(NO) supply to the extracorporeal circulation <https://www.sciencedirect.com/topics/medicine-and-dentistry/extracorporeal-circulation> circuit for cardioprotection <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-protection> against -ischemiareperfusion injury <https://www.sciencedirect.com/topics/medicine-and-dentistry/reperfusion-injury> during coronary artery bypass grafting <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-bypass-graft> (CABG) with cardiopulmonary bypass <https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiopulmonary-bypass> (CPB). Methods -A total of 60 patients with coronary artery disease <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-disease> scheduled for CABG with CPB were enrolled in a prospective randomized study. Patients were allocated randomly to receive treatment according to standard or modified CPB protocol where 40-ppm NO was added to the CPB circuit during cardiac surgery <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-surgery>. The primary endpoint was the measurement of cardiac troponin I <https://www.sciencedirect.com/topics/medicine-and-dentistry/troponin-i> (cTnI). The secondary end points consisted in the measurements of creatine kinase-muscle/brain fraction (CK-MB) and vasoactive inotropic <https://www.sciencedirect.com/topics/medicine-and-dentistry/inotropism> score (VIS). | ||
| 330 | |a Results - NO delivered into the CPB circuit had a cardioprotective effect. The level of cTnI was significantly lower in NO-treated group compared with the control group 6 hours after surgery: 1.79 ± 0.39 ng/mL versus 2.41 ± 0.55 ng/mL, respectively (P = .001). The CK-MB value was significantly lower in NO-treated group compared with the control group 24 hours after surgery: 47.69 ± 8.08 U/L versus 62.25 ± 9.78 U/L, respectively (P = .001); and the VIS was significantly lower in the NO-treated group 6 hours after the intervention. Conclusions - NO supply to the CPB circuit during CABG exerted a cardioprotective effect and was associated with lower levels of VIS and cardiospecific blood markers cTnI and CK-MB. | ||
| 333 | |a Режим доступа: по договору с организацией-держателем ресурса | ||
| 461 | |t The Journal of Thoracic and Cardiovascular Surgery | ||
| 463 | |t Vol. ХХХ |v [10 p.] |d 2018 | ||
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a cardioprotection | |
| 610 | 1 | |a ischemia-reperfusion injury | |
| 610 | 1 | |a nitric oxide | |
| 610 | 1 | |a cardiopulmonary bypass | |
| 610 | 1 | |a coronary artery bypass grafting | |
| 610 | 1 | |a шунтирование | |
| 610 | 1 | |a оксид азота | |
| 610 | 1 | |a ишемия | |
| 701 | 1 | |a Kamenshchikov |b N. O. |g Nikolay Olegovich | |
| 701 | 1 | |a Mandel |b I. A. |g Irina Arkadjevna | |
| 701 | 1 | |a Podoksenov |b Yu. K. |g Yury Kirilovich | |
| 701 | 1 | |a Svirko |b Yu. S. |g Yulia Stanislavovna | |
| 701 | 1 | |a Anfinogenova |b Ya. J. |c Linguist |c Lecturer of Tomsk Polytechnic University, Doctor of medical sciences |f 1970- |g Yana Jonovna |3 (RuTPU)RU\TPU\pers\33592 | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет |b Инженерная школа новых производственных технологий |b Научно-образовательный центр Н. М. Кижнера |3 (RuTPU)RU\TPU\col\23556 |
| 801 | 2 | |a RU |b 63413507 |c 20190227 |g RCR | |
| 856 | 4 | |u https://doi.org/10.1016/j.jtcvs.2018.08.117 | |
| 942 | |c CF | ||